Filing Details
- Accession Number:
- 0000899866-20-000098
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-21 17:00:35
- Reporting Period:
- 2020-12-17
- Accepted Time:
- 2020-12-21 17:00:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899866 | Alexion Pharmaceuticals Inc. | ALXN | Pharmaceutical Preparations (2834) | 133648318 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1768214 | Daniel Bazarko | C/O Alexion Pharmaceuticals, Inc. 121 Seaport Boulevard Boston MA 02210 | Svp, Controller, Cao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.0001 Per Share | Acquisiton | 2020-12-17 | 13,066 | $97.58 | 43,949 | No | 4 | M | Direct | |
| Common Stock, Par Value $.0001 Per Share | Acquisiton | 2020-12-17 | 11,000 | $140.16 | 54,949 | No | 4 | M | Direct | |
| Common Stock, Par Value $.0001 Per Share | Disposition | 2020-12-17 | 9,900 | $157.59 | 45,049 | No | 4 | S | Direct | |
| Common Stock, Par Value $.0001 Per Share | Disposition | 2020-12-17 | 13,066 | $157.76 | 31,983 | No | 4 | S | Direct | |
| Common Stock, Par Value $.0001 Per Share | Disposition | 2020-12-17 | 1,100 | $158.00 | 30,883 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.0001 Per Share | Common Stock | Disposition | 2020-12-17 | 13,066 | $0.00 | 13,066 | $97.58 |
| Common Stock, Par Value $.0001 Per Share | Common Stock | Disposition | 2020-12-17 | 11,000 | $0.00 | 11,000 | $140.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-06-01 | No | 4 | M | Direct | |
| 0 | 2026-02-28 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $157.75 - $157.79. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- Beginning June 1, 2013, options became exercisable 25% after one year and 1/16 every three months thereafter until fully vested over 4 years.
- Beginning February 26, 2016, options became exercisable 25% after one year and 1/16 every three months thereafter until fully vested over 4 years.
Billionaire Hedge Funds
